Relmada Therapeutics Inc. (RLMD)
NASDAQ: RLMD
· Real-Time Price · USD
0.63
0.02 (3.75%)
At close: Aug 15, 2025, 3:59 PM
0.65
1.88%
After-hours: Aug 15, 2025, 04:10 PM EDT
3.75% (1D)
| Bid | 0.58 |
| Market Cap | 21.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -75.71M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -0.29 |
| Forward PE | -0.58 |
| Analyst | Hold |
| Ask | 0.7 |
| Volume | 181,691 |
| Avg. Volume (20D) | 421,148 |
| Open | 0.61 |
| Previous Close | 0.61 |
| Day's Range | 0.59 - 0.66 |
| 52-Week Range | 0.24 - 3.98 |
| Beta | 0.67 |
About RLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RLMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RLMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
-9.03%
Relmada Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
11 months ago
+13.53%
Relmada Therapeutics shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $3.5 to $13.
